Breaking News

Thermo Fisher Opens New Facility in China

November 16, 2012

Will manufacture plastic labware and consumables

Thermo Fisher Scientific has opened its new facility in Suzhou, China, for the manufacture of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities in China and other Asia-Pacific markets.
 
The company has invested nearly $20 million in the 12,000-square-meter Suzhou plant, which will house more than 150 employees and includes room for expansion. The new facility will primarily serve the life sciences and pharmaceutical industries, including research, diagnostics and bioproduction, as well as customers in the chemical, environmental and electronics industries.
 
In Suzhou, the company will manufacture plastic labware and consumables, including sample preparation products and filterware, as well as lab refrigerators, freezers, incubators and centrifuges, and will follow global and local manufacturing practices, including ISO9001, ISO14001 and ISO13485 standards.
 
“China is one of our fastest-growing markets and has been a key contributor to our success,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The Suzhou facility builds on our well-established presence in China and is an important next step as we closely align our depth of capabilities with China’s five-year plan to develop strategic industries, including pharmaceutical, healthcare and environmental.”
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • What is Driving the Outsourcing Market?

    What is Driving the Outsourcing Market?

    Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences||January 29, 2015
    CRO industry generates healthy partnerships through co-development of drugs, diagnostics and demand for functional services.